How the Los Angeles Times shilled for the racist eugenics movement
By Alexandra Minna Stern,
Los Angeles Times
| 02. 28. 2021
Last month, Caltech announced that the names of six men with historical ties to the university would be removed from all“campus buildings, assets, and honors.”This unnaming came as the institution renounced its historical connections to the Human Betterment Foundation, a zealous pro-eugenics organization that influenced and admired Nazi racial hygiene policies in the 1930s and 1940s. Caltech determined that prominent trustees of the foundation, such as Caltech’s inaugural president and Nobel laureate Robert A. Millikan, no longer deserved to be commemorated at the university.
Also among the six whose names will be scrubbed from Caltech was Harry Chandler, who served as publisher of the Los Angeles Times from 1917 until his death in 1944.
Caltech was correct to recognize the pivotal role of the Human Betterment Foundation in spreading the eugenics gospel. The brainchild of wealthy agribusinessman Ezra Gosney, the foundation — through its biased studies, cherry-picked data collection, propagandizing and political sway — was instrumental in making California the most aggressive sterilizer of any of the 32 U.S. states that passed eugenic sterilization laws. From 1909 to...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...